Abstract
The goal of the intense research on stem cells is for human application. Recently, knowledge of stem cells has progressed rapidly and experimental therapies are already in clinical trials. However, for more far reaching application and successful therapy much more remains to be learned about stem cells. There are many more questions than answers. What is a stem cell? What different kinds are there? Can they be obtained and manipulated? What are the lineages that derive from stem cells, and how plastic are cells in a lineage? Are there circulating stem cells in adults? Do they participate in repair of injury? What type of stem cell is most appropriate for a given clinical application? New technologies need to be developed to apply to stem cells for effective gene delivery. What role, if any, does fusion of stem cells play in tissue regeneration? Can the differentiation potential of stem cells at different stages of determination be used to select cells for specific clinical applications? What are the signals that recruit, activate, and induce differentiation in stem cells? What are the signaling pathways for activation and differentiation of stem cells, and can they be manipulated to advantage? How can stem cells be used to understand carcinogenesis and developmental abnormalities? Are embryonic stem cells, which have the potential to produce progeny that can differentiate into any adult tissues the best cells for therapeutic use? Or in some instances, are adult stem cells resident in adult tissues or circulating adult bone marrow derived cells a better choice? How can immune rejection of transplanted cells be avoided or prevented? Will therapeutic cloning, whereby transfer of somatic nuclei to provide an embryonic cell line that matches the patient, become clinically applicable? Can embryonic germ cells be used to greater advantage that embryonic stem cells? Will adult stem cells, if they can be isolated and cultured, be a better choice for selected use, for example, in replacing cells in a specific damaged organ. Are there adult multipotent stem cells or can adult tissue-determined stem cells transdifferentiate to another tissue cell type? If so, how can this be controlled? Does fusion play a role in functional stem cell plasticity and can a way to use fusion to direct tissue repair or replacement be devised? Do human somatic cells have the capacity for dedifferentiation, such as found during regeneration of tissues in amphibians? Can this phenomenon be applied to mammalian tissues and eventually used clinically? How can genetic modification of human embryonic or adult stem cells be improved and applied? The potential of stem cell therapy has great promise and is only limited by our incomplete knowledge of what stem cells are and how they function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aboody, K. S., Brown, A., Rainov, N. G., et al. (2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA 97:12,846–12,851.
Alison, M. R., Poulsom, R., Jeffery, R., et al. (2000) Hepatocytes from non-hepatic adult stem cells. Nature 406:257.
Amit, M., Carpenter, M. K., Inokuma, M. S., et al. (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227:271–278.
Anderson, D. J., Gage, F. H., and Weissman, I. L. (2001) Can stem cells cross lineage boundaries? Nat. Med. 7:393–395.
Barr, E., and Leiden, J. M. (1991) Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254:1507–1509.
Bjornson, C. R., Rietze, R. L., Reynolds, B. A., Magli, M. C., and Vescovi, A. L. (1999) Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283:534–537.
Blau, H. M. (2002) A twist of fate. Nature 419:437.
Blau, H. M., and Baltimore, D. (1991) Differentiation requires continuous regulation. J. Cell Biol. 112:781–783.
Blau, H. M., Brazelton, T. R., and Weimann, J. M. (2001) The evolving concept of a stem cell: entity or function? Cell 105:829–841.
Blau, H. M., Chiu, C. P., and Webster, C. (1983) Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32:1171–1180.
Blau, H. M., Pavlath, G. K., Hardeman, E. C., et al. (1985) Plasticity of the differentiated state. Science 230:758–766.
Blau, H. M., and Springer, M. L. (1995a) Gene therapy-a novel form of drug delivery. N. Engl. J. Med. 333:1204–1207.
Blau, H. M., and Springer, M. L. (1995b) Muscle-mediated gene therapy. N. Engl. J. Med. 333:1554–1556.
Brazelton, T. R., Rossi, F. M., Keshet, G. I., and Blau, H. M. (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775–1779.
Brazelton, T. R., Rossi, F. M., Keshet, G. I., and Blau, H. M. (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775–1779.
Chambers, I., Colby, D., Robertson, M., et al. (2003) Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643–655.
Chiu, C. P., and Blau, H. M. (1984) Reprogramming cell differentiation in the absence of DNA synthesis. Cell 37:879–887.
Clarke, D. L., Johansson, C. B., Wilbertz, J., et al. (2000) Generalized potential of adult neural stem cells. Science 288:1660–1663.
Dani, C., Chambers, I., Johnstone, S., et al. (1998) Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dev. Biol. 203:149–162.
Dhawan, J., Pan, L. C., Pavlath, G. K., Travis, M. A., Lanctot, A. M., and Blau, H. M. (1991) Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254:1509–1512.
Dick, J. E., Magli, M. C., Huszar, D., Phillips, R. A., and Bernstein, A. (1985) Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/W mice. Cell 42:71–79.
Ferrari, G., Cusella-De Angelis, G., Coletta, M., et al. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528–1530.
Gussoni, E., Soneoka, Y., Strickland, C. D., et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390–394.
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., et al. (2000) Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6:88–95.
Jackson, K. A., Majka, S. M., Wang, H., et al. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107:1395–1402.
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41–49.
Kaufman, D. S., Hanson, E. T., Lewis, R. L., Auerbach, R., and Thomson, J. A. (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 98:10,716–10,721.
Kielman, M. F., Rindapaa, M., Gaspar, C., et al. (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of betacatenin signaling. Nat. Genet. 32:594–605.
Kim, J. H., Auerbach, J. M., Rodriguez-Gomez, J. A., et al. (2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature 418:50–56.
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430–436.
Kondo, T., and Raff, M. (2000) Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289: 1754–1757.
Krause, D. S., Theise, N. D., Collector, M. I., et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369–377.
LaBarge, M. A. and Blau, H. M. (2002) Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111:589–601.
Lagasse, E., Connors, H., Al-Dhalimy, M., et al. (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6:1229–1234.
Laurencin, C. T., Attawia, M. A., Lu, L. Q., et al. (2001) Poly(lactideco-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials 22:1271–1277.
Lovell-Badge, R. (2001) The future for stem cell research. Nature 414: 88–91.
McDonald, J. W., Liu, X. Z., Qu, Y., et al. (1999) Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5:1410–1412.
Mezey, E., Chandross, K. J., Harta, G., Maki, R. A., and McKercher, S. R. (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779–1782.
Min, J. Y., Yang, Y., Converso, K. L., et al. (2002) Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92:288–296.
Mitsui, K., Tokuzawa, Y., Itoh, H., et al. (2003) The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631–642.
Mohajeri, M. H., Figlewicz, D. A., and Bohn, M. C. (1999) Intramuscular grafts of myoblasts genetically modified to secrete glial cell linederived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum. Gene Ther. 10:1853–1866.
Nichols, J., Zevnik, B., Anastassiadis, K., et al. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379–391.
Niwa, H., Burdon, T., Chambers, I., and Smith, A. (1998) Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12:2048–2060.
Nolta, J. A., Dao, M. A., Wells, S., Smogorzewska, E. M., and Kohn, D. B. (1996) Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immunedeficient mice. Proc. Natl. Acad. Sci. USA 93:2414–2419.
Odelberg, S. J., Kollhoff, A., and Keating, M. T. (2000) Dedifferentiation of mammalian myotubes induced by msxl. Cell 103:1099–1109.
Odorico, J. S., Kaufman, D. S., and Thomson, J. A. (2001) Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19: 193–204.
Orlic, D., Kajstura, J., Chimenti, S., et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705.
Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996) Longterm lymphohematopoietic reconstitution by a single CD34-low/ negative hematopoietic stem cell. Science 273:242–245.
Ozawa, C. R., Springer, M. L., and Blau, H. M. (2000a) Ex vivo gene therapy using myoblasts and regulatable retroviral vectors. In Gene Therapy: Therapeutic Mechanisms and Strategies, (N. S. Templeton, and D. D. Lasic, eds.) Marcel Dekker, New York, NY, pp. 61–80.
Ozawa, C. R., Springer, M. L., and Blau, H. M. (2000b) A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors. Annu. Rev. Pharmacol. Toxicol. 40:295–317.
Park, F., Ohashi, K., Chiu, W., Naldini, L., and Kay, M. A. (2000) Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24:49–52.
Partridge, T. A. (2003) Stem cell route to neuromuscular therapies. Muscle Nerve 27:133–141.
Pereira, R. F., Halford, K. W., O’Hara, M. D., et al. (1995) Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 92:4857–4861.
Pereira, R. F., O’Hara, M. D., Laptev, A. V., et al. (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 95:1142–1147.
Rathjen, P. D., Lake, J., Whyatt, L. M., Bettess, M. D., and Rathjen, J. (1998) Properties and uses of embryonic stem cells: prospects for application to human biology and gene therapy. Reprod. Fertil. Dev. 10:31–47.
Reik, W., Dean, W., and Walter, J. (2001) Epigenetic reprogramming in mammalian development. Science 293:1089–1093.
Reya, T., Duncan, A. W., Ailles, L., et al. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409–414.
Reyes, M., Dudek, A., Jahagirdar, B., Koodie, L., Marker, P. H., and Verfaillie, C. M. (2002) Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109:337–346.
Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., and Verfaillie, C. M. (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615–2625.
Rheinwald, J. G., and Green, H. (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331–343.
Rideout, W. M., 3rd, Hochedlinger, K., Kyba, M., Daley, G. Q., and Jaenisch, R. (2002) Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109:17–27.
Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and Rudnicki, M. A. (2000) Pax7 is required for the specification of myogenic satellite cells. Cell 102:777–786.
Shamblott, M. J., Axelman, J., Littlefield, J. W., et al. (2001) Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl. Acad. Sci. USA 98:113–118.
Shamblott, M. J., Axelman, J., Wang, S., et al. (1998) Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 95:13,726–13,731.
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., and Blau, H. M. (1998) VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol. Cell 2:549–558.
Surani, M. A. (2001) Reprogramming of genome function through epigenetic inheritance. Nature 414:122–128.
Szilvassy, S. J., Fraser, C. C., Eaves, C. J., Lansdorp, P. M., Eaves, A. C., and Humphries, R. K. (1989) Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc. Natl. Acad. Sci. USA 86:8798–8802.
Terada, N., Hamazaki, T., Oka, M., et al. (2002) Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542–545.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
Thomson, J. A., Kalishman, J., Gois, T. G., et al. (1995) Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 92: 7844–7848.
Toma, J. G., Akhavan, M., Fernandes, K. J., et al. (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3:778–784.
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., and Gage, F. H. (2002) Functional neurogenesis in the adult hippocampus. Nature 415:1030–1034.
Verfaillie, C. M., Pera, M. F., and Lansdorp, P. M. (2002) Stem cells: hype and reality. Hematology (Am. Soc. Hematol. Educ. Program):369–391.
Waldmann, H. (2001) Therapeutic approaches for transplantation. Curr. Opin. Immunol. 13:606–610.
Weimann, J. M., Charlton, C. A., Brazelton, T. R., Hackman, R. C., and Blau, H. M. (2003) Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc. Natl. Acad. Sci. USA 100:2088–2093.
Willert, K., Brown, J. D., Danenberg, E., et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448–452.
Wilson, S. I., Rydstrom, A., Trimborn, T., et al. (2001) The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature 411:325–330.
Ying, Q. L., Nichols, J., Evans, E. P., and Smith, A. G. (2002) Changing potency by spontaneous fusion. Nature 416:545–548.
Zuk, P. A., Zhu, M., Mizuno, H., et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7:211–228.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Doyonnas, R., Blau, H.M. (2004). What Is the Future for Stem Cell Research?. In: Sell, S. (eds) Stem Cells Handbook. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-411-5_43
Download citation
DOI: https://doi.org/10.1007/978-1-59259-411-5_43
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-367-1
Online ISBN: 978-1-59259-411-5
eBook Packages: Springer Book Archive